Abstract
Nosocomial fungal infection increases gradually and has become the leading pathogen at National Taiwan University Hospital since 1993. From January 1995 through May 2002, hepatosplenic fungal infection (HSF) was diagnosed in 37 (7.4%) of the 500 adult patients with acute leukemia who received chemotherapy at this hospital. There was no significant difference in the incidence of HSF between the patients with acute myeloid leukemia and those with acute lymphoblastic leukemia, or between the patients treated with high-dose chemotherapy and those with conventional or low-dose chemotherapy. Candida tropicalis was the leading pathogen, followed by Candida albicans. The computed tomography scan showed multiple hypodense lesions in the liver (89%), spleen (70%), and kidney (27%). Eighteen patients were initially treated with fluconazole and 19 with amphotericin B. Nineteen patients received the planned chemotherapy after the diagnosis of HSF. Among them, eight patients underwent hematopoietic stem cell transplantation and seven patients survived more than 100 days post-transplantation; none of these patients had relapse of prior HSF. Twenty-three patients (62%) died during a median follow up of 10 months, but only seven died due to HSF. In conclusion, a substantial percentage of patients with acute leukemia acquired HSF after chemotherapy and carried high mortality. However, HSF itself is not a contraindication for subsequent chemotherapy and hematopoietic stem cell transplantation.
Similar content being viewed by others
References
DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA (1982) Fungal infection in patients with acute leukemia. Am J Med 73:543–548
Antilla VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P (1997) Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 24:375–380
Bjerke JW, Meyers JD, Bowden RA (1994) Hepatosplenic candidiasis: a contraindication to marrow transplantation. Blood 84:2811–2814
Sallah S (1999) Hepatosplenic candidiasis in patients with acute leukemia: increasingly encountered complication. Anticancer Res 19:757–760
Rossetti F, Brawner DL, Bowden R, Meyer WG, Schoch HG, Fisher L, Myerson D, Hackman RC, Shulman HM, Sale GE, Meyers JD, McDonald GB (1995) Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors and clinical features. Clin Infect Dis 20:801–811
Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P (1999) Hepatosplenic candidiasis in patients with acute leukemia. Br J Hematol 106:697–701
Haron E, Feld R, Tuffinell P, Patterson B, Hasselback R, Maltow A (1987) Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med 83:17–26
Anttila VJ, Ruutu P, Bondestam S, Jansson SE, Nordling S, Farkkila M, Sivonen A, Castren M, Ruutu T (1994) Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 18:979–981
Anttila VJ, Farkkila M, Jansson SE, Taavitsainen M, Kaukoranta-Tolvanen SS, Nordling S, Koukila-kahkola P, Ruutu T, Ruutu P (1997) Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis. Eur J Clin Microbiol 16:637–643
Pestalozzi BC, Krestin GP, Schanz U, Jacky E, Gmur J (1997) Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia. Blood 90:3858–3864
Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14
Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678
Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT (1997) Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 18:369–375
Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Krcmery V, De pauw B, Meunier F, et al. (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28:1071–1079
Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15:414–421
Chen YC, Lin SF, Liu CJ, Jiang DD, Yang PC, Chang SC (2001) Risk factors for ICU mortality in critically ill patients. J Formos Med Assoc 100:656–661
Chen YC, Chang SC, Tai HM, Hsueh PR, Luh KT (2001) Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 100:791–797
Woolley I, Curtis D, Szer J, Fairley C, Vujovic O, Ugoni A, Spelman D (1997) High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia. Leuk Lymphoma 27:469–474
Semelka RC, Kelekis N, Sallah S, Worawattanakul S, Ascher SM (1997) Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 169:1311–1316
Sallah S, Semelka RC, Kelekis N, Worawattanakul S, Sallah W (1998) Diagnosis and monitoring response to treatment of hepatosplenic candidiasis in patients with acute leukemia using magnetic resonance imaging. Acta Hematol 100:77–81
Shirkhoda A (1987) CT findings in hepatosplenic and renal candidiasis. J Comput Assist Tomogr 11:795–798
Pastakia B, Shawker TH, Thaler M, O'Leary T, Pizzo PA (1998) Hepatosplenic candidiasis: wheels within wheels. Radiology 166:417–421
Karthaus M, Ganser A (2000) Hepatosplenic candidiasis in patients with acute leukemia. Br J Haematol 109:672
Thaler M, Pastakia B, Shawker TH, O'leary T, Pizzo PA (1988) Hepatic candidiasis in cancer patients: the evolving pictures of the syndrome. Ann Intern Med 18:88–100
Lewis JH, Patel HR, Zimmerman HJ (1982) The spectrum of hepatic candidiasis. Hepatology 2:479–487
Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC (1996) Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95:19–28
De Repentigny L, Phaneuf M, Mathieu LG (1992) Gastrointestinal colonization and systemic dissemination by C. albicans and C. tropicalis in intact and immunocompromised mice. Infect Immun 60:4907–4914
Wang JT, Yao M, Tang JL, Chang SC, Hung CC (2001) Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol 19:4000–4001
Walsh TJ, Whitcomb PO, Revankar SG, Pizza PA (1995) Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 76:2357–2362
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, CY., Chen, YC., Tang, JL. et al. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 82, 93–97 (2003). https://doi.org/10.1007/s00277-002-0588-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-002-0588-7